91 related articles for article (PubMed ID: 10977930)
21. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
Ogata S; Maimonis PJ; Itzkowitz SH
Cancer Res; 1992 Sep; 52(17):4741-6. PubMed ID: 1511439
[TBL] [Abstract][Full Text] [Related]
22. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
[TBL] [Abstract][Full Text] [Related]
23. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.
Morse MA; Deng Y; Coleman D; Hull S; Kitrell-Fisher E; Nair S; Schlom J; Ryback ME; Lyerly HK
Clin Cancer Res; 1999 Jun; 5(6):1331-8. PubMed ID: 10389916
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of immunotherapy efficiency in mouse CaO-1 ovarian carcinoma treated by vaccines based on dendritic cells.
Sitdikova SM; Kiselevskii MV; Sel'chuk VY; Amandzholov BS; Kurbatova EA; Donenko FV
Bull Exp Biol Med; 2009 Feb; 147(2):226-8. PubMed ID: 19513427
[TBL] [Abstract][Full Text] [Related]
25. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting.
Jia F; Shelton TD; Lewis MR
Cancer Biother Radiopharm; 2007 Oct; 22(5):654-64. PubMed ID: 17979568
[TBL] [Abstract][Full Text] [Related]
27. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment.
Liu KJ; Chao TY; Chang JY; Cheng AL; Ch'ang HJ; Kao WY; Wu YC; Yu WL; Chung TR; Whang-Peng J
J Biomed Sci; 2016 Aug; 23(1):64. PubMed ID: 27558635
[TBL] [Abstract][Full Text] [Related]
28. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of serum mucin-associated antigen in adult patients with cystic fibrosis.
Robinson CB; Martin WR; Ratliff JL; Holland PV; Wu R; Cross CE
Am Rev Respir Dis; 1993 Aug; 148(2):385-9. PubMed ID: 8342902
[TBL] [Abstract][Full Text] [Related]
30. [Increased level of carcinoembryonal antigen is not primarily a marker for ovarian cancer].
Kristensen CA; Roed HM
Ugeskr Laeger; 2005 Jan; 167(2):189; author reply 190. PubMed ID: 15697136
[No Abstract] [Full Text] [Related]
31. Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.
Höchst B; Schildberg FA; Böttcher J; Metzger C; Huss S; Türler A; Overhaus M; Knoblich A; Schneider B; Pantelis D; Kurts C; Kalff JC; Knolle P; Diehl L
Hepatology; 2012 Nov; 56(5):1924-33. PubMed ID: 22610745
[TBL] [Abstract][Full Text] [Related]
32. Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen.
Pervin S; Chakraborty M; Bhattacharya-Chatterjee M; Zeytin H; Foon KA; Chatterjee SK
Cancer Res; 1997 Feb; 57(4):728-34. PubMed ID: 9044852
[TBL] [Abstract][Full Text] [Related]
33. Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye.
Argüeso P; Tisdale A; Spurr-Michaud S; Sumiyoshi M; Gipson IK
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):113-9. PubMed ID: 16384952
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
[TBL] [Abstract][Full Text] [Related]
35. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen-transgenic mice: a model for tumor immunotherapy.
Eades-Perner AM; Zimmermann W
Tumour Biol; 1995; 16(1):56-61. PubMed ID: 7863223
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated antigens as immunotherapy targets.
Phillips NC; Major PP; Sikorska H
Cancer Detect Prev; 1988; 12(1-6):451-9. PubMed ID: 3263200
[TBL] [Abstract][Full Text] [Related]
38. Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development.
Zhang X; Hu S; Du X; Li T; Han L; Kong J
J Microbiol Immunol Infect; 2016 Dec; 49(6):851-858. PubMed ID: 25641594
[TBL] [Abstract][Full Text] [Related]
39. Production and characterization of monoclonal antibodies against human airway mucins.
Shin CY; Lee WJ; Kim DJ; Park CS; Park SH; Ko KH
Hybridoma; 1999 Oct; 18(5):457-63. PubMed ID: 10600033
[TBL] [Abstract][Full Text] [Related]
40. Another oncofoetal antigen in colonic carcinoma.
Ma J; de Boer WG; Ward HA; Nairn RC
Br J Cancer; 1980 Feb; 41(2):325-8. PubMed ID: 6989384
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
